Neurontin (Gabapentin)

Gabapentin, the active ingredient in Neurontin, is an anticonvulsant presented as an oral tablet for oral use. It is employed to manage partial seizures, post‑herpetic neuralgia, diabetic peripheral neuropathic pain, and restless‑legs syndrome in adult patients. It is indicated for neurological pain conditions and as adjunct therapy for epilepsy.

GNH USA supplies Neurontin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements across multiple markets, with reliable logistics and support.

Gabapentin is an anticonvulsant that modulates neuronal excitability in various neurological conditions.

- Partial seizures: reduces seizure frequency when used as adjunct therapy. - Postherpetic neuralgia: alleviates chronic pain following shingles. - Diabetic peripheral neuropathic pain: eases burning and tingling sensations in the limbs. - Restless legs syndrome: diminishes uncomfortable leg sensations and urge to move.

Gabapentin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Somnolence: increased sleepiness or fatigue. - Peripheral edema: swelling of the lower extremities. - Weight gain: gradual increase in body weight. - Visual disturbances: blurred vision or double vision. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Angioedema: rapid swelling of face, lips, tongue, or throat. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal ideation: emergence of thoughts of self‑harm. - Respiratory depression: slowed breathing, especially with CNS depressants. - Blood dyscrasias: aplastic anemia or agranulocytosis. - Hepatic failure: signs of liver dysfunction.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

- Assess renal function: adjust dose in patients with impaired clearance. - Monitor mood changes: watch for depression or suicidal thoughts. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal seizures. - Use caution in elderly: increased sensitivity to sedation and falls. - Review concomitant CNS depressants: consider additive sedation. - Store at room temperature: keep in the original pack, protect from moisture.

Gabapentin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce gabapentin absorption. - Opioids (e.g., morphine, oxycodone): increase risk of respiratory depression and profound sedation. - Alcohol: potentiates central nervous system depression. - CNS depressants (benzodiazepines, barbiturates): may cause excessive sedation. - Certain antiepileptics (e.g., phenobarbital): may decrease gabapentin levels.

Moderate Interactions (Monitor Closely): - NSAIDs: may increase risk of renal impairment. - ACE inhibitors or ARBs: monitor kidney function and blood pressure. - Diuretics: watch for electrolyte disturbances. - Oral contraceptives: minimal effect, but monitor for reduced efficacy. - Antidepressants (SSRIs, SNRIs): observe for enhanced central effects.